Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Some birth control pills have a higher risk of blood clots than others.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Citrate is a safer alternative to heparin for preventing blood clots in hemodialysis.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Ritlecitinib can help about 14,000 people with severe hair loss.

The HCR gene contributes to psoriasis risk.

CRH causes hair loss by reducing cell survival in hair follicles.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

RTA 408 cream protects mice from radiation skin damage.

Cepharanthine can help treat tick-borne encephalitis virus by reducing stress and inflammation.

Systemic retinoids do not increase COVID-19 risk or severity.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.